Clinical Trial Update: A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a human monoclonal antibody against Staphylococcus aureus alpha toxin in mechanically ventilated adults with ventilator-associated pn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection
• Ventilator-associated Pneumonia

Drugs mentioned

• Monoclonal antibody against Staphylococcus aureus alpha toxin (undisclosed brand) (monoclonal antibody targeting Staphylococcus aureus alpha toxin)

Snippet

Sponsor: Aridis Pharmaceuticals, Inc. | Conditions: Ventilator Associated Pneumonia, Staphylococcus Aureus | Phase 3 | Status: TERMINATED